LABORATOIRES EUROMEDIS (ALEMG.PA) Stock Analyst Earnings Estimates
EPA:ALEMG - Euronext Paris - Matif - FR0000075343 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 111.901M -42.14% | 54.183M -51.58% | 34.039M -37.18% | 64.684M 90.03% | 69.558M 7.54% | 42.65M -38.68% | |
| EBITDA YoY % growth | N/A -71.39% | -4.564M -147.14% | N/A 147.39% | 2.987M 38.10% | 3.218M 7.73% | 1.962M -39.03% | |
| EBIT YoY % growth | 3.699M -87.10% | -5.569M -250.55% | -8.919M -60.15% | 1.854M 120.79% | 2.076M 11.97% | 1.321M -36.37% | |
| Operating Margin | 3.31% | -10.28% | -26.20% | 2.87% | 2.98% | 3.10% | |
| EPS YoY % growth | N/A -55.20% | N/A -160.59% | N/A 112.14% | 0.41 60.00% | 0.45 8.35% | 0.47 5.81% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 18.266M -26.01% | % | ||
| Q4 2023 Q2Q % growth | 34.039M 36.96% | % | ||
| Q2 2023 Q2Q % growth | 24.688M -15.82% | % | ||
| Q4 2022 Q2Q % growth | 24.854M -37.85% | % | ||
| Q2 2022 Q2Q % growth | 29.329M -59.22% | % | ||
| Q4 2021 Q2Q % growth | 39.989M -69.69% | % | ||
| Q2 2021 Q2Q % growth | 71.912M 17.01% | % | ||
| Q4 2020 Q2Q % growth | 131.95M 240.94% | % | ||
| Q2 2020 Q2Q % growth | 61.459M 60.13% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |